Study on the Surgical Strategy of Corneal Endothelial Protection for Hard Nuclear Cataract Patients
Key facts
- Who runs it
- Eye & ENT Hospital of Fudan University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 207 people enrolled
- Started
- 10 Aug 2022
- Ended
- 1 Mar 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- combined burst mode
- torsional mode
- Record updated
- 28 May 2025
Who can take part
- Age
- 50 years to 95 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (7)Hide the full registry criteria
Who can take part
- patients with age-related cataracts that were only classified by Emery-Little as nuclear hardness grade III-V
- encompassed a minimum dilated pupil diameter of 7 mm or above, as well as a corneal endothelial cell count exceeding 1200/mm\^2
- Corneal morphology is normal and clear
- Informed consent is required prior to enrollment
Who cannot take part
- Exclude those with previous intraocular surgery
- Those with white cataracts, histories of eye surgery, and eye diseases such as corneal pathology, uveitis, Fuchs\' dystrophy, and glaucoma were excluded
- Exclude those with comorbid ocular and systemic diseases that affect corneal endothelial cell function
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In this study, we compared two types of phacoemulsification commonly used in cataract surgery to evaluate their effect on the prognosis of patients with hard nuclei. This will provide a theoretical basis for selecting a more appropriate cataract surgery modality in practice in hard-nucleus patients.
The 2 groups in the trial
- Combined burst modeTreatment being tested
combining the torsional and vertical ultrasound under burst mode(Burst Tor+ Burst US) Phacoemulsification mode Brust mode Torsional amplitude 0-90% Longitudinal power 40% Infusion system Gravity fed Bottle height 50-80 cm Vacuum 360 mmHg Aspiration flow rate 30 cm3/min Burst duration 70 ms Off time 50 ms
- torsional modeExisting treatment, for comparison
torsional mode under continues mode (Linear Tor) Phacoemulsification mode Continuous mode Torsional amplitude 0-90% Longitudinal power 0 Infusion system Gravity fed Bottle height 50-80 cm Vacuum 360 mmHg Aspiration flow rate 30 cm3/min Burst duration - Off time -
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Combined Burst Mode Versus Torsional Mode Phacoemulsification for Patients With Hard Nuclear Cataract: A Randomized Control Study
- Publications
- Combined Burst Mode versus Torsional Mode Phacoemulsification for Patients with Hard Nuclear Cataracts: A Prospective Comparative Cohort Study.Clinical ophthalmology (Auckland, N.Z.), 2026
- Record updated
- 28 May 2025